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Maladaptive responses to stress adversely affect
human behavior, yet the signaling mechanisms un-
derlying stress-responsive behaviors remain poorly
understood. Using a conditional gene knockout
approach, the a isoform of p38 mitogen-activated
protein kinase (MAPK) was selectively inactivated
by AAV1-Cre-recombinase infection in specific brain
regions or by promoter-driven excision of p38a
MAPK in serotonergic neurons (by Slc6a4-Cre or
ePet1-Cre) or astrocytes (by Gfap-CreERT2). Social
defeat stress produced social avoidance (a model
of depression-like behaviors) and reinstatement of
cocaine preference (a measure of addiction risk) in
wild-type mice, but not in mice having p38a MAPK
selectively deleted in serotonin-producing neurons
of the dorsal raphe nucleus. Stress-induced activa-
tion of p38aMAPK translocated the serotonin trans-
porter to the plasma membrane and increased the
rateof transmitter uptake at serotonergic nerve termi-
nals. These findings suggest that stress initiates a
cascade of molecular and cellular events in which
p38aMAPK induces a hyposerotonergic state under-
lying depression-like and drug-seeking behaviors.
INTRODUCTION
Stress has significant effects on mood and can act as a motiva-
tional force for decisive action, seeking food or reward, and
coping with novel environmental conditions. However, sustained
stress exposure can lead to maladaptive responses including
clinical depression, anxiety, and increased risk for drug addiction
(Bale and Vale, 2004; Krishnan and Nestler, 2008; Bruchas et al.,498 Neuron 71, 498–511, August 11, 2011 ª2011 Elsevier Inc.2010; Koob, 2008). Recent studies have proposed that the
dysphoric components of stress are coded in brain by cortico-
tropin releasing factor (CRF) and subsequent release of the
endogenous dynorphin opioid peptides in brain (Land et al.,
2008; Bruchas et al., 2010; Koob 2008). Systemic blockade of
these neural pathways prevents the aversive and proaddictive
effects of stress, but how these systems orchestrate affective
responses at the molecular and cellular levels remain
unresolved.
One group of signaling pathways involved in the cellular stress
response includes the family of mitogen-activated protein
kinases (MAPK). Using pharmacological approaches, p38
MAPK (also called SAPK, for stress-activated protein kinase)
activity has been identified as a critical mediator of stroke-
induced apoptosis, osmotic shock response, and in the regula-
tion of transcriptional pathways responsible for cell death and
differentiation (Raman et al., 2007; Coulthard et al., 2009).
Recently however, inhibition of p38 MAPK was also found to
block stress-induced behavioral responses including aversion
(Land et al., 2009; Bruchas et al., 2007) and to prevent reflex-
conditioned responses (Zhen et al., 2001). Although the cellular
andmolecular bases for these behavioral actions are not known,
one possible site of action is the serotonergic nuclei because this
transmitter has an established role in the regulation of mood
(Roche et al., 2003; Paul et al., 2011; Richardson-Jones et al.,
2010). The dorsal raphe nucleus (DRN) is the primary neuronal
source of serotonin, and DRN neurons send diffuse projections
to multiple forebrain and hindbrain structures that are critical
for regulating affective state (Land et al., 2009; Hensler 2006;
Zhao et al., 2007). The DRN is modulated by several afferent
systems (Wylie et al., 2010; Land et al., 2009; Scott et al.,
2005; Kirby et al., 2008), but how these inputs regulate serotonin
neurotransmission remains unclear, and little is known about the
essential signal transduction kinase cascades in the DRN that
regulate serotonergic output to ultimately control behavior.
In the DRN, we found that p38aMAPK expression was widely
distributed in tryptophan hydroxylase 2 (TPH) expressing cells,
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Deletion of p38a Produces Stress Resiliencenon-TPH cells, and astrocytes (Land et al., 2009). Several reports
have demonstrated that there is a high degree of coexpression
between the serotonin transporter (Slc6a4, SERT) and TPH posi-
tive neurons (MacGillivray et al., 2010; Lowry et al., 2008). Recent
studies have also determined that expression of the transcription
factor Pet1 is largely restricted to serotonergic (TPH-immunore-
active, ir) neurons (Scott et al., 2005; Liu et al., 2010). Thus, SERT
and Pet1 represent potentially useful markers for the discrimina-
tion of serotonergic neurons within the brain. Here, we used
a combination of conditional p38a MAPK null alleles generated
in serotonergic neurons or astrocytes to determine the effects
of p38a MAPK deletion in models of depression behaviors
including place aversion and social avoidance and of drug
addiction behaviors modeled by reinstatement of extinguished
cocaine place preference.
RESULTS
p38aMAPK in DRN Is Required for Behavioral
Responses to Stress
Since prior reports suggested that p38 MAPK is activated
during the stress response, we first determined if social defeat
stress (SDS) induces phosphorylation of p38 MAPK in the DRN.
Following a single, 20 min session of SDS, mice showed an
increase in phospho-p38 immunoreactivity (pp38-ir) in the
DRN (Figures 1A and 1A1). G protein coupled receptor activa-
tion can lead to p38 MAPK phosphorylation via recruitment of
arrestin-dependent pathways (Tan et al., 2009; Gong et al.,
2008), and activation of the dynorphin/kappa opioid receptor
(KOR) system was shown to increase pp38-ir by this mecha-
nism (Bruchas et al., 2006, 2007). Consistent with this concept,
the increase in pp38-ir caused by SDS was prevented by
blocking endogenous dynorphin activation of KOR with the
selective antagonist norbinaltorphimine (norBNI) (Figures 1A
and 1A1).
There are four isoforms of p38 MAPK: a, b, d, and g. p38a and
p38b are both expressed in neurons and glial cells, whereas
p38d and p38g are exclusively expressed in immune cell types
(Zhang et al., 2007; Zarubin and Han, 2005). Since the p38
isoforms share consensus phosphorylation sites and there are
no known isoform-selective phospho-antibodies, we used non-
phospho-selective, but isoform-selective antibodies in immuno-
precipitation approaches to determine the phosphorylation state
of each isoform. Agonist stimulation of KOR resulted in signifi-
cant (p < 0.05, t test) phosphorylation of the p38a, but not
p38b isoform (see Figure S1A available online) in HEK293 cells
expressing KOR-GFP and either FLAG-tagged p38a or p38b
isoforms. No difference in immunoprecipitation efficiency or iso-
form expression was observed (Figure S1B) as evidenced by
equal FLAG staining. Finally, using nucleus accumbens cell
lysates, we found that in vivo treatment with KOR agonist
increased pp38a-ir (Figure S1C). Together these data suggest
that KOR activation during stress exposure selectively increased
the phosphorylation of the a isoform of p38 MAPK.
To determine if p38a activation in DRNwas required for stress-
induced behavioral responses, we used a genetic approach to
selectively inactivate p38a MAPK in DRN cells. Using mice
with a floxed gene (Mapk14lox/lox) encoding p38aMAPK (Nishidaet al., 2004), local inactivation of p38a MAPK in the DRN was
achieved by stereotaxic injection of adeno-associated virus
serotype 1 vector encoding Cre recombinase (AAV1-CreGFP)
(Ahmed et al., 2004). These mice were also bred to carry a
Gt(ROSA)26Sor-YFP (R26-YFP) reporter cassette in which Cre-
mediated recombination of a transcriptional STOP promotes
YFP expression as a marker of Cre activity (Figure 1B). p38a-ir
was absent in AAV1-CreGFP transduced cells that coexpressed
the YFP reporter (Figure 1C). In contrast, injection of AAV1-
CreDGFP vector expressing an inactive, mutated form of the
Cre-recombinase (CreD) did not affect p38a MAPK expression
in DRN (Figure 1C).
Prior reports established that stress causes relapse to drug
seeking (Nestler and Hyman, 2010; Krishnan et al., 2007), and
in particular, social defeat stress (SDS) represents an ethologi-
cally relevant stressor for evoking dysphoria-like behavioral
states (Miczek et al., 2008). TheMapk14lox/lox mice were injected
in the DRN with AAV1-CreGFP to determine whether p38a
MAPKwas required for SDS induced reinstatement.We followed
this injection with a conditioning paradigm for cocaine place
preference (Figure 1D). Both AAV1-CreGFP and AAV1-CreDGFP
injected mice developed normal place preference to cocaine
(Figure 1E), suggesting that deletion of p38a in DRN cells does
not disrupt associative learning components required for initial
acquisition of cocaine place preference. We then extinguished
the conditioned preference by substituting saline for cocaine in
the drug-paired chamber (Figure 1D). After mice met extinction
criteria (%15% of their initial preference score; Figure 1E),
mice were exposed to social defeat stress (20 min session)
and then place preference was reassessed. Importantly, AAV1-
CreGFP-induced deletion of p38a in the DRN completely
blocked SDS-induced reinstatement of cocaine CPP, whereas
floxed p38a mice injected with the virus expressing the inactive
form of Cre recombinase still showed robust SDS-induced rein-
statement of cocaine CPP (Figure 1E). These data suggest that
expression of p38a in the DRN is required for stress-induced
reinstatement of reward seeking behavior.
To expand on this concept and to parallel other studies
showing that stress negatively modulates reward to initiate
the drive for reward seeking (Koob, 2008), we injected
Mapk14lox/lox (floxed p38a) mice with either AAV1-CreGFP or
AAV1-CreDGFP in either the DRN or nucleus accumbens
(NAc), and then assessed conditioned avoidance of a context
paired with an aversive stimulus. Since KOR activation results
from stress and is known to produce aversive behavioral
responses in stress-paired contexts (Land et al., 2008, 2009;
Bruchas et al., 2010; Carlezon et al., 1998; Shippenberg et al.,
1986) we conditioned mice with the KOR agonist U50,488
(2.5 mg/kg, i.p.) over 2 days and then assessed their avoidance
of the drug-paired context. AAV1-CreGFP injection in the DRN of
Mapk14lox/lox mice, but not the NAc, blocked conditioned place
aversion (Figure 1F). This result suggests that p38a MAPK in
the DRN is also required for stress-induced dysphoria-like avoid-
ance behavior.
Selective Disruption of p38a in 5HT Neurons
p38a MAPK is ubiquitously expressed in cells of DRN including
serotonergic and nonserotonergic neurons, aswell as astrocytesNeuron 71, 498–511, August 11, 2011 ª2011 Elsevier Inc. 499
Figure 1. p38a Expression in the Dorsal Raphe Nucleus Is Required for Stress Behavior
(A) Representative low-power immunofluorescence images of social defeat stress induced pp38-ir (green) in TPH-ir cells (red) of the DRN. (A1) Quantification ±
SEM of pp38-ir in DRN from unstressed (naive), social defeat stress (SDS), and social defeat stress exposed norBNI (10mg/kg, i.p.) injectedmice (**p < 0.01, SDS
versus naive). Inset, representative black and white low power immunofluorescence images of social defeat stress induced pp38-ir, scale bar = 200 mm.
(B) Schematic of AAV1 induced cre-recombination of the floxed p38a MAPK allele and STOP sequence controlling Rosa26YFP gene expression.
(C) Representative images of pp38-ir (red) and YFP (green) fluorescence following AAV1-Cre-GFP or AAV1-DCre-GFP injection into the DRN. Mice were pre-
treated with KOR agonist (U50,488, 20 mg/kg, i.p, 20 min prior to perfusion). Images show that AAV-cre expressing cells lack pp38-ir, confirming effective
localized DRN p38a deletion in cells where Cre activity also promoted YFP expression by the Rosa reporter.
(D) Conditioning procedure for SDS induced reinstatement of cocaine seeking.
(E) Cocaine place preference scores, calculated as post-test minus pre-test on the cocaine-paired side, and SDS-induced reinstatement scores of extinguished
place preference in DRN-injected animals (n = 5–8; *p < 0.05 t test compared to AAV1-DCre). Bars represent means ± SEM.
(F) Preference scores (mean ± SEM) for conditioned place aversion to kappa opioid agonist U50,488 (2.5 mg/kg, i.p.) frommice injected with either AAV1cre-GFP
or AAV1Dcre-GFP into their DRN or nucleus accumbens (NAc) (*p < 0.05, AAV1cre-GFP versus AAV1Dcre-GFP; n = 8).
See also Figure S1.
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Deletion of p38a Produces Stress Resilience(Figure S2A). Since AAV1-CreGFP transduction provides
anatomical specificity but is not cell type specific, we crossed
the Mapk14lox/lox mice with mice expressing Cre-recombinase
under control of either the 5HT transporter gene Slc6a4Cre
(SERT-Cre) (Zhuang et al., 2005), the enhancer region of 5HT-
cell-type specific transcription factor Pet-1 (ePet1-Cre) (Scott
et al., 2005), or the estrogen receptor-inducible Cre variant under
control of the astrocyte selective glial fibrillary acidic protein
gene (GFAP-Cre-ERT2) (Hirrlinger et al., 2006) inducible Cre
mouse line (Figure 2A). Due to the potential for transient and vari-
able expression of promoter driven Cre in germ cells, males
carrying the Cre recombinase alleles had an inactive Mapk14
gene (Mapk14D/+), and they were crossed with females carrying
Mapklox/lox (see Figure S2B for breeding scheme and Table 1 for
abbreviations of each genotype used in this study). In addition, to
confirm that Cre-mediated recombination by Slc6a4-Cre, ePet1-
Cre, or Gfap-Cre-ERT2 were cell type specific, we also crossed
thesemice with theR26-YFP reporter mice (Srinivas et al., 2001).
We then used double immunofluorescence staining to detect
yellow fluorescent protein (YFP) and tryptophan hydroxylase 2
(TPH), the rate-limiting enzyme for serotonin synthesis in brain
and a marker for serotonergic neurons (Nakamura and Hase-
gawa, 2007). We observed a high level of TPH-ir and YFP coex-
pression in the DRN, but not in the cortex or hippocampus of
p38a CKOePet (Mapk14D/lox: ePet1-Cre) mice (Figures 2B and
S3A–S3H). Further, as would be predicted from the wide expres-
sion profile of SERT during neurodevelopment (Murphy and
Lesch, 2008), we visualized a high level of TPH-ir and YFP coex-
pression in the DRN (Figure 2C), but YFP expression was also
observed in cells of the cortex and hippocampus and thalamus
of p38aCKOSERT (Mapk14D/lox: Slc6a4-Cre) mice (Figure S3A).
Finally, p38aCKOGFAP (Mapk14D/lox: GFAP-CreERT2) mice
showed no YFP colocalization with TPH-ir neurons in the DRN,
but showed extensive YFP signal in cells of astrocytic
morphology throughout the brain including the DRN, thus estab-
lishing consistent cell-type selective Cre-recombinase activity
(Figure 2C).
The degree of p38a MAPK expression was also examined in
the DRN of conditional knockout (CKO) mice using antibodies
directed at p38a or phospho-p38 MAPK. p38aCKOePet mice
displayed significantly reduced p38a MAPK expression in
TPH-ir cells (ANOVA, Bonferroni post hoc, p < 0.001; Figures
2F and 2J) in contrast to p38a expression in wild-type mice
(Figure 2E). In p38a CKOSERT mice, p38a-ir in the DRN was
also significantly reduced in TPH-ir cells compared to the wild-
type mice (ANOVA, Bonferroni post-hoc, p < 0.001; Figures 2G
and 2J). Importantly, expression of TPH-ir was not altered in
any of the knockout mouse lines (Figures 2H, 2I, 2K, and 2L),
nor was p38a MAPK expression significantly altered in non-
TPH expressing cells of CKO mice (Figure 2M). Finally, we did
not observe compensatory changes in p38b MAPK expression
in DRN cells in any of the mouse lines (Figure S3I). To determine
if the active isoform of p38 MAPK was selectively disrupted
in TPH expressing cells, we injected mice with the KOR agonist
U50,488 and then stained for pp38-ir. In wild-type mice,
agonist stimulation of KOR increased pp38-ir in DRN, however
p38aCKOePet mice showed no increase in pp38-ir in DRN
following KOR stimulation (Figures 2K and 2L).Serotonergic p38a Is Required for Stress-Induced
Avoidance Behavior
Previous reports have demonstrated that mice subjected to
defeat by an aggressor mouse show subsequent decreases in
motivation for social interaction that can be prevented by clini-
cally effective antidepressants (Nestler and Hyman 2010; Cao
et al., 2010; Berton et al., 2006; Avgustinovich and Kovalenko,
2005; Siegfried, 1985). Using this approach, we assessed the
role of p38a MAPK in stress-induced social avoidance. Previ-
ously unstressed mice readily explore and interact with a novel
male mouse in the social interaction chamber (Figures 3A and
3B). However, socially defeatedmice showed a significant social
avoidance (ANOVA, F(2,29) = 2.51, p<0.05,Bonferroni; Figure 3A).
Pretreatment with the KORantagonist norBNI (24 hr prior to SDS,
10 mg/kg, i.p) significantly blocked the SDS-induced avoidance
behavior (ANOVA, F(3,30) = 2.843, p < 0.05, Bonferroni). As ex-
pected, littermate control mice (Mapk14D/+: ePet1-Cre) showed
avoidance behavior following SDS, whereas p38a CKOePet
mice were resilient to the effects of social defeat and showed
significant reduction in the SDS-induced interaction deficit
(t test, p < 0.05; Figure 3B). Because social avoidance behavior
may also be considered to be an anxiety-like response, we deter-
mined if behavior in the elevated plus maze was also affected by
disruption of p38a MAPK in serotonergic neurons (Figure S4B).
Unexpectedly, there were no significant differences in the time
spent in the open arms of the maze by the p38aCKOePet, p38aC-
KOSERT, and littermate control groups (Figure S4B), suggesting
that the blockade of SDS-induced social avoidance caused by
serotonergic p38a MAPK deletion was not a consequence of
a generalized decrease in anxiety-like responses.
Avoidance behavior is a complex response known to be regu-
lated by serotonergic systems as well as other hormones and
neuropeptides (Bari et al., 2010; Eriksson et al., 2011; Cao
et al., 2010; Bromberg-Martin et al., 2010; Pamplona et al.,
2011). To determine if context-dependent avoidance requires
serotonergic p38a MAPK expression, we assayed conditioned
place aversion (CPA) to U50,488, a KOR agonist that acts
as a pharmacological stressor. KOR activation causes aversion
behavior in rodents in Pavlovian conditioning paradigms
(Shippenberg et al., 1986; Land et al., 2009). We conditioned
mice with U50,488 (2.5 mg/kg, i.p.) over 2 days and then as-
sessed their preference for the drug-paired context. As ex-
pected, wild-type and Mapk14D/lox mice showed significant
CPA to the drug-paired context (Figures 3C and 3D). In contrast,
mice lacking p38aMAPK in either their ePet-1 or SERT-express-
ing cells (p38aCKOePet or p38aCKOSERT, respectively) failed to
show significant place aversion (for p38aCKOePet, ANOVA,
F(2,19) = 5.626, p < 0.05 Bonferroni; for p38aCKO
SERT, ANOVA,
F(2,32) = 4.193, p < 0.05 Bonferroni; Figures 3C and 3D). Since
previous studies have shown SERT is also expressed in astro-
cytes (Hirst et al., 1998; Bal et al., 1997; Pickel and Chan,
1999) and to further confirm 5HT neuronal selectivity of the
behavioral effects, we induced Cre activity by tamoxifen in
p38aCKOGFAP (Mapk14D/lox:Gfap-CreERT2) then assayed their
behavioral responses to KOR agonist. Although Cre activity
was confirmed in astrocytes of tamoxifen-treated p38aCKOGFAP
mice (Figure 2D), they still developed significant CPA (Figure 3E),
suggesting that aversion does not require p38a MAPKNeuron 71, 498–511, August 11, 2011 ª2011 Elsevier Inc. 501
Figure 2. Cell Type Selective Deletion of p38a MAPK
(A) Schematic of cell type specific p38a deletion. Floxed p38a andROSAYFP reportermicewere crossed tomice expressingCre-recombinase under the control of
Pet1, serotonin transporter, or the tamoxifen inducible glial fibrillary acidic protein (GFAP) CreERT2 transgene. Representative images showing TPH-ir and YFP in
p38aCKOePet mice (B), p38aCKOSERT (C), and p38aCKOGFAP (D) mice. Insets show higher-power images with arrows directed toward yellow cells indicating
overlap of TPH/YFP expression. Representative images showing TPH and p38a-ir in wild-type (E), p38aCKOePet (F), and p38aCKOSERT (G). Representative
images fromwild-typemice showing the absence of phosphorylated p38MAPK (pp38-ir) following saline treatment (H) and increased pp38-ir following treatment
with U50,488 20 mg/kg, i.p., 20 min prior) (I). Insets show intact TPH labeling in the same fields.
(J) Quantitation of p38a-ir in TPH positive cells in the dorsal raphe nucleus. Data show a significant reduction in p38a expression in both p38a CKOePET and p38a
CKOSERT mice (***p < 0.001, ANOVA, Bonferroni).
(K) Representative images from in p38a CKOePET mice showing the absence of pp38-ir following saline treatment (K) and following treatment with U50,488 (L).
Insets show intact TPH staining.
(M) Quantitation of p38a-ir expressed in TPH-negative cells in the DRN. Data are representative of 4–8 animals per group.
See also Figure S3.
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Table 1. Mouse Cell Lines Generated
Official Strain Name Reference Shorthand Name Genotype
B6.129-Mapk14tm1.2Otsu Nishida et al., 2004 floxed p38a Mapk14lox/lox
p38a+/+ Mapk14+/+
B6.129-Tg(Slc6a4-cre)1Xz Zhuang et al., 2005 p38a CKOSERT Mapk14D/lox; Slc6a4Cre/+
p38aD/lox Mapk14D/lox
p38alox/+ Mapk14lox/+
SERT-Cre only Mapk14+/+: Slc6a4Cre/+
B6.129-Tg(ePet-cre)1Esd Scott et al., 2005 p38a CKOePet Mapk14D/lox: ePetCre
p38aD/lox Mapk14D/lox
p38alox/+ Mapk14lox/+
ePet-Cre only Mapk14+/+: ePetCre
B6.129-Tg(Gfap-creERT2)1Fki Hirrlinger et al., 2006 p38a CKOGFAP Mapk14lox/lox: GfapCre-ERT2
floxed p38a Mapk14lox/lox
B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J Srinivas et al., 2001 ROSA-YFP Rosa26EYFP/+ heterozygote as reporter
for Cre in genotypes above
B6.129S4-Meox2tm1(cre)Sor/J Tallquist and Soriano, 2000 Mox2-Cre As heterozygote to produce
null p38aD allele
B6.129(Cg)-Slc6a4tm1Kpl/J Bengel et al., 1998 Conventional SERT KO Slc6a4/
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requires locomotor activity for normal exploratory behavior and
aversive compounds such as KOR agonists can reduce locomo-
tion, we also measured locomotor activity in p38a CKOs and
controls. We did not observe any effect of genotype on basal
or U50,488-induced locomotor scores before or during condi-
tioning (Figure S4C), suggesting that the lack of context depen-
dent place aversion to a pharmacological stressor is not attribut-
able to a deficit in locomotor activity or lack of pharmacological
activation of KOR.
Serotonergic systems have been widely studied in models of
depression and many groups use forced swim stress (FSS) as
an animal model of stress-induced affect and for measuring
behavioral efficacy of anti-depressant-like compounds (Porsolt
et al., 1977). To determine if p38a MAPK deletion in SERT-ex-
pressing cells prevents swim stress-immobility, we exposed
mice to FSS and then measured their immobility during the first
trial andagain24hr later.p38aCKOSERTmiceshowedsignificantly
less immobility compared to control groups (Figure 3F; ANOVA,
F (2,15) = 8.924, p < 0.01 Bonferroni). Furthermore, since previous
reports have suggested that stress causes dynorphin-dependent
analgesia (McLaughlin et al., 2003), we determined if deletion of
p38a MAPK altered stress-induced analgesic responses.
Following swim stress, all control groups and p38aCKOSERT
mice showed equivalent and significant stress-induced analgesia
(Figure S4), suggesting that p38a MAPK deletion does not alter
stress-induced dynorphin release or KOR activation. Taken
together, these data indicate that p38a MAPK in serotonergic
neuronsplayacritical role in themodulationofaffectivebehavioral
responses including avoidance and stress-induced immobility.
p38aMAPK Deletion Blocks Social Defeat
Stress-Induced Reinstatement
Because negative affect and drug seeking responses share
common neural and molecular pathways, we next determinedif p38a MAPK deletion in serotonergic neurons prevents
stress-induced reinstatement of drug seeking. First, we used
immunohistochemistry to determine if SDS-induced increases
in pp38-ir were prevented in the CKO mice. Consistent with
previous results in this study, SDS did not cause an increase in
pp38-ir in TPH-ir cells in p38aCKOSERT or p38aCKOePet mice
(Figures 4A and S3J). In contrast, SDS increased pp38-ir in
TPH-ir cells of p38aCKOGFAP mice, further supporting selective
isolation of stress-induced p38a to serotonergic neurons (Fig-
ure S3J). Next we used a similar conditioning procedure as in
Figure 1 to determine if serotonergic p38aMAPKdeletion altered
cocaine place preference. All groups showed similar levels of
place preference for cocaine (Figure 4B), suggesting that
deletion of serotonergic p38a does not alter either the associa-
tive learning required for place preference or the rewarding
properties of cocaine. We then extinguished place preference
over 3 days, and mice that met extinction criteria were socially
defeated, then tested in the place preference apparatus. We
found that SDS caused reinstatement of cocaine place prefer-
ence in both wild-type and control Mapk14D/+ mice, but stress-
induced reinstatement was not evident in p38aCKOSERT or
p38aCKOePet mice (t test, p < 0.05 versus matched control;
Figure 4C). Finally, since cocaine injection (i.e., priming) is known
to initiate reinstatement to drug seeking by distinct mechanisms
(Thomas et al., 2008; Shaham and Hope, 2005), on the following
day mice that did not reinstate to stress were injected with
15 mg/kg of cocaine and retested for place preference. All
four groups of mice reinstated following a cocaine priming
injection (Figure 4D), suggesting that serotonergic p38a MAPK
deletion selectively alters only stress-induced modulation
of drug-seeking. In conclusion, these results implicate seroto-
nergic p38a MAPK in the regulation of affective state and show
that selective deletion of p38a MAPK in serotonergic cells
protects mice from stress-induced relapse of cocaine-seeking
behaviors.Neuron 71, 498–511, August 11, 2011 ª2011 Elsevier Inc. 503
Figure 3. Negative Affective Behavior Requires Expression of p38a in Serotonergic Neurons
(A) Representative traces of mouse locomotion (red lines) in unstressed and social defeat stressed wild-type or mice lacking p38a in serotonergic neurons
(p38a CKOePet). Data show that SDS caused mice to retreat to zone 2 or 3 (Z2, 3, far corners). Mice pretreated with norBNI (10 mg/kg, i.p., 24 hr prior) or with
serotonergic p38a deletion (p38aCKOePet) show normal exploration of the interaction zone (IZ).
(B) Quantification of social interaction scores in mice following SDS. Dashed line represents the social interaction scores for unstressed mice (n = 8, *p < 0.05
versus control saline or p38aD/lox, t test).
(C) Place Preference scores following conditioning with U50,488 (2.5 mg/kg) in wild-type, p38aD/lox and p38aCKOePet mice (n = 8–10, ANOVA, p < 0.05 versus
control).
(D) Place Preference scores (means ± SEM following conditioning with U50,488 (2.5mg/kg) in p38awild-type versus p38a D/lox and p38aCKOSERTmice (n = 8–10,
ANOVA, p < 0.05 versus control).
(E) Place Preference scores ± SEM following conditioning with U50,488 (2.5 mg/kg) in wild-type or p38aCKOGFAP mice (n = 6–8).
(F) Swim-stress induced immobility scores for wild-type mice, p38aD/lox, or p38aCKOSERT (data are means ± SEM; ANOVA, *p < 0.01, n = 6–8).
See also Figure S3.
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Figure 4. Disruption of p38a in Serotonergic Neurons Protects against SDS-Induced Reinstatement of Drug Seeking
(A) Representative images of SDS induced phospho-p38-ir in each mouse line. Data show an absence of SDS-induced pp38-ir in TPH-ir cells in both
p38aCKOSERT and p38aCKOePet mice but show an intact increase in pp38-ir in TPH-ir cells of p38a CKOGFAP mice. (Pixel intensities of pp38-ir were quantified
from these and replicate images and shown in Figure S3J.) SDS did not significantly increase pp38-ir in DRN of p38aCKOePet or p38aCKOSERT, whereas pp38-ir
was significantly increased in DRN of p38aCKOGFAP mice.
(B) Mouse place preference scores (±SEM) following cocaine (15 mg/kg, s.c.) conditioning.
(C) Mouse place preference scores (±SEM) after extinction and following social defeat (p < 0.05, ANOVA, Bonferroni post hoc).
(D) Mouse place preference scores following extinction then cocaine priming (15 mg/kg, s.c.) (n = 8–20). See also Figure S4 for additional behavioral charac-
terization.
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To define the mechanism for the effects of p38a MAPK, we
looked to studies in heterologous gene expression systems
that previously suggested the plasma membrane serotonin
transporter could be a p38 MAPK substrate (Zhu et al., 2005;
Samuvel et al., 2005). Building on in vitro data showing that
p38 MAPK increases SERT activity, we first asked whether the
serotonergic p38a-dependent CPA response was sensitive to
the selective SERT reuptake inhibitor citalopram (Ravna et al.,
2003). Mice were conditioned as previously described with a
KOR agonist and then assayed for preference to the stressor-
paired context. Control mice showed normal place aversion to
the U50,488-paired compartment, whereas citalopram-pre-
treatedmice (15mg/kg, i.p. 30min prior to KOR agonist) showed
significantly less U50,488 place aversion (Figure 5A; ANOVA,
F(2,15) = 4.082, Bonferroni, p < 0.05 versus saline). These behav-
ioral data strongly implicate the regulation of extracellular sero-
tonin as a plausible mechanism for p38a-dependent effects.To determine if p38a MAPK activation actually modulates
SERT function in vivo, we used rotating disk electrovoltammetry
(RDEV), a validated measure of monoamine transport kinetics
(McElvain and Schenk, 1992; Burnette et al., 1996; Earles and
Schenk, 1998; Hagan et al., 2010), to measure 5HT uptake
rates in synaptosomes isolated from stressed or unstressed
mice. To isolate G protein-coupled receptor-mediated p38a
MAPK activation and to mimic the conditioned aversion para-
digm described above, mice received either saline or U50,488
(2.5 mg/kg, i.p.) 24 hr prior to and again 30 min prior to prepara-
tion of whole-brain synaptosomes. Synaptosomes isolated from
mice injected with KOR agonist (Figure 5C) showed a marked
increase rate of SERT specific 5HT clearance compared with
synaptosomes from control, saline-injected mice (Figures 5B
and 5D). This increase in uptake rate was blocked by in vivo
pretreatment with norBNI (2 3 2 ANOVA, significant effect of
pretreatment, p < 0.05; Figure 5D). We then determined whether
deletion of p38a in serotonergic cells blocked the KOR inducedNeuron 71, 498–511, August 11, 2011 ª2011 Elsevier Inc. 505
Figure 5. Investigation of 5HT Uptake by SERT
(A) Place preference scores (±SEM) following conditioning of wild-type mice treated either with U50,488 (2.5 mg/kg) (U50/Saline), with the selective SERT re-
uptake inhibitor citalopram (CPM) (15 mg/kg, i.p., 30 min prior to U50,488) (U50/CPM), or with citalopram alone (Saline/CPM). Citalopram prior to KOR agonist
significantly blocked U50,488 CPA (ANOVA, p < 0.05, n = 8–10).
(B and C) Representative RDEV traces of 5-HT uptake from paroxetine (red traces) and nonparoxetine (black traces) treated synaptosomes isolated from control
(B) or U50,488 (2.5 mg/kg, i.p. 32)-treated animals (C). Note the larger difference in slope for U50,488 treated than control animals.
(D) Administration of U50,488 (2.5mg/kg, i.p.32, 24 hr apart) to mice, 30min prior to synaptosomal isolation, increased 5-HT uptake by SERT compared to saline
treated controls (n = 10–16, *p < 0.01). This effect of U50,488 was blocked by pretreatment of the mice with norBNI (10 mg/kg).
(E) Administration of U50,488 (2.5 mg/kg, i.p.32), increased serotonin uptake by SERT in synaptosomes generated from p38a+/+, p38aD/lox, and p38a+/+,SERTcre
mice, but not from p38aCKOSERT mice (n = 10–16, *p < 0.05).
(F) Administration of U50,488 (2.5 mg/kg, i.p.32) 30 min prior to preparation of synaptosomes did not significantly increase serotonin uptake by the low-affinity
transporters (n = 10–16).
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saline control, p < 0.05) and control Mapk14D/lox mice (t test
versus saline control, p < 0.001) showed a significant U50,488-
mediated increases in SERT uptake as compared to saline
treated animals of the same genotype (Figure 5E). In contrast,
KOR stimulation did not significantly increase 5HT uptake in
p38aCKOSERT (Mapk14D/lox: Slc6a4-Cre) mice (t test versus
control, p < 0.01) (Figure 5E), suggesting that p38a MAPK dele-
tion prevented modulation of SERT activity. Because 5HT can
also be taken up by a low-affinity, high-capacity transporter
(Daws, 2009), we also examined the rate of 5HT uptake in the
combined presence of selective NET, SERT, DAT inhibitors.
The low-affinity transport was not significantly changed by
treatment with KOR agonist in vivo (Figure 5F). Taken together
these results strongly suggest that SERT activity in nerve termi-
nals of serotonergic neurons is positively modulated in a p38a
MAPK-dependent manner.506 Neuron 71, 498–511, August 11, 2011 ª2011 Elsevier Inc.p38a MAPK Regulates SERT Cell-Surface Trafficking
To determine if the increase in uptake rate was caused by
increased SERT expression, we isolated synaptosomes and
immunoblotted for SERT in each mouse genotype. Consistent
with previous reports (Samuvel et al., 2005; Zhu et al., 2005),
we found that SERT-ir migrates at both 75 and 98 KDa (Fig-
ure 6A). We confirmed the selectivity of the two different SERT
antibodies by showing an absence of staining in synaptosomes
isolated from SERT knockout mice (Figure 6A) and absence of
SERT-ir in untransfected HEK293 cells, but presence in cells
transfected with cDNA encoding SERT (Figure S5). Total SERT
expression in p38aCKOSERT or p38aCKOεPεt mice was not
significantly different from wild-type mice (Figures 6A and S5).
Using a membrane impermeant biotinylation procedure to
label cell-surface proteins (Samuvel et al., 2005), we next as-
sessed changes in SERT-ir expression on the synaptosomal
surface. SDS (20 min exposure) of wild-type mice significantly
Figure 6. p38a MAPK Is Required for Social Defeat Stress-Induced Cell Surface SERT Trafficking
(A) Representative immunoblot of total SERT levels in the different mouse lines used in this study. Data show both species of SERT (75 and 98 kDa) are present in
these strains and the absence of SERT-ir in the Slc6a4 knockout (SERT-KO) mouse. Actin-ir was used to control for protein loading.
(B) Representative immunoblot of surface SERT expression in biotinylated synaptosomes isolated from unstressed mice (no stress), from mice after SDS, and
from mice pretreated with norBNI (10 mg/kg) 24 hr prior to SDS. (Anti-streptavidin-ir confirms equal protein loading after biotinylation and pull-down.
(C) Quantification of SERT-ir surface expression following SDS of saline-treated wild-type, norBNI-treatedwild-type, and p38aCKOePet mice (*p < 0.05, **p < 0,01,
***p < 0.001, ANOVA, Bonferroni post-hoc).
(D) Quantification of SERT-ir surface expression following U50,488 treatment of wild-type and p38a CKOePet mice. (*p < 0.05, t test). n = 8–10 in replicate, and
each was taken from a separate animal.
(E) Cartoon model depicting p38a MAPK-dependent SERT translocation and decreased extracellular 5HT.
See also Figure S5.
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Deletion of p38a Produces Stress Resilienceincreased (ANOVA, F(2,24) = 4.7122, p < 0.05) synaptosomal
surface SERT expression (Figure 6), and this increase was
blocked by pretreatment with norBNI (10 mg/kg, i.p.) 1 hr prior
to SDS (Figures 6B and 6C). Furthermore, socially defeated
(20 min exposure) or KOR agonist treated (2.5 mg/kg, 2 3
24 hr, i.p.) p38a CKOePet mice did not show stress-induced
increases in surface SERT expression, defining a critical role
for p38a MAPK in SERT surface trafficking following stress and
KOR activation (Figures 6C and 6D). The proposed mechanism
of p38a MAPK-SERT interaction is illustrated in Figure 6E.
DISCUSSION
In this study, we present evidence that p38aMAPK is an essen-
tial mediator of stress-induced adverse behavioral responses
through regulation of serotonergic neuronal functioning. Our
data demonstrate that p38a expression in 5HT neural circuits
is required for local regulatory control of serotonin transport
that ultimately controls behavioral responses including social
avoidance, relapse of drug seeking, and the dysphoria-like
responses underlying aversion. These results are important
because they implicate a critical requirement for p38a MAPK
signaling in 5HT neuronal function during stress, and demon-
strate that p38a MAPK, in spite of its ubiquitous expression
profile, has the ability to specifically regulate selected down-
stream targets to shape behavioral output. The evidence pre-
sented here strongly links molecular events, physiological
responses and behavioral output through p38a MAPK signaling
actions in serotonergic neurons.
The dorsal raphe nucleus (DRN) contains a major cluster of
serotonergic neurons that project broadly throughout the brain
(Wylie et al., 2010). Its circuits have impact on mood regulation
and nociception (Scott et al., 2005; Zhao et al., 2007). However,
the DRN is not homogeneous and contains a diversity of cell
types whose local circuit interactions and projections are not
completely defined (Wylie et al., 2010). Expression of the tran-
scription factor Pet1 during development is highly correlated
with the production of TPH, the rate-limiting enzyme in 5HT
synthesis (Liu et al., 2010; Scott et al., 2005). GABA and glutama-
tergic inputs are known to regulate tonic DRN neuronal activity
(Lemos et al., 2011; Tao and Auerbach, 2000), although how
these different systems are integrated remains an active area of
study. All serotonergic cell bodies express SERT perisynaptically
at their terminal regions to clear extracellular 5HT following trans-
mitter release (Murphy and Lesch, 2008). Using the selective
expression of Cre driven by SERT and Pet1 promoters, we found
that thegenetic inactivationof p38aMAPK inPet1- andSERT-ex-
pressing cells causeda lossof p38aandpp38 staining selectively
in TPH ir-positive cells of DRN.Wewere not surprised to find that
expression of Cre driven by the SERT promoter was widespread
(Figure S3) because transient SERT expression during brain
development had previously been noted (Gaspar et al., 2003;
Narboux-Neˆme et al., 2008). Nevertheless, the SERT-Cre mice
provide important corroborative results consistent with the
effects of two other tools we used to excise p38a in serotonergic
neurons. The selectivity of Cre expression and subsequent p38a
excision by AAV1-CreGFP, SERT-Cre or ePet1-Cre are demon-
strably different. AAV1-CreGFP acts on all DRN cells at the site508 Neuron 71, 498–511, August 11, 2011 ª2011 Elsevier Inc.of injection; SERT-Cre expression was not restricted to DRN;
and ePet1-Cre is expressed in TPH-ir neurons of the median
raphe as well as DRN. Nevertheless, the consistent behavioral
results suggest the p38a deletion in the common TPH-ir cells of
DRN mediates these effects. In addition, although p38-depen-
dent stress responses also include activation, hypertrophy, and
proliferation of astrocytes (Xu et al., 2007), we found no evidence
that activation of p38a in GFAP-ir astrocytes was involved in the
behavioral responses assessed. The lack of effect of p38a dele-
tion in astrocytes was surprising since other investigators have
noted that many aspects of the brain’s response to stress
resemble inflammation (Wager-Smith and Markou, 2011).
The conditional deletion of p38a and lack of compensation by
p38b caused profound behavioral effects in models of stress-
induced depression and addiction and establishes a distinct
role of the p38a isoform over p38b isoforms in dorsal raphe
function. The selective role for the p38a MAPK isoform was
unexpected but is consistent with prior reports suggesting that
the a and b isoforms may be expressed in different subcellular
compartments (Lee et al., 2000). In addition, differences in func-
tional roles are consistent with isoform differences in other
signaling kinases including the various PKC isoforms (Hauben-
sak et al., 2010; Sajikumar and Korte, 2011).
The 5HT transmitter system inmammalian brain is known to be
an essential modulator of homeostatic responses that control
emotional behaviors and the interaction of animals with their
environments (Holmes, 2008; Ansorge et al., 2004; Gingrich
and Hen, 2001). It is widely accepted that 5HT function is neces-
sary for the normal functioning of neural circuits required for
adult emotional behaviors (Gaspar et al., 2003). However, few
studies have identified the critical kinases involved in seroto-
nergic function, and few have established how disruption of
signal transduction in serotonergic neurons impacts emotional
behaviors. Pharmacological blockade of p38 MAPK has been
suggested to prevent conditioned place aversion and learned
helplessness in animal models of depression (Bruchas et al.,
2007). Furthermore, expression of mutant kappa opioid recep-
tors that are ineffective at activating p38 MAPK prevents place
aversion in behavioral assays (Land et al., 2009). However,
a definitive role for p38 MAPK in behavioral regulation following
stress had not previously been directly demonstrated.
Rodent models of social interaction have gained acceptance
by neurobiologists as useful models of depression-like behavior
since they respond to antidepressant compounds, and the
DSM-IV criteria includes decreasedmotivation for social interac-
tion as major component of human depression (Berton et al.,
2006; Beidel et al., 2010). p38a MAPK may represent the first
kinasemediator in a series of neurochemical events that underlie
the chronic behavioral changes. The block of social avoidance
by KOR antagonist further establishes the dynorphin system as
a critical part of the stress response and strengthens the concept
that this system may be a novel therapeutic target to promote
stress resilience (Land et al., 2008, 2009; Bruchas et al., 2010).
The regulation of extracellular serotonin levels and subsequent
postsynaptic effects have long been thought to be a primary
component of depression and anhedonic behavioral responses
in humans (Haenisch and Bo¨nisch, 2011); however, few reports
have demonstrated that interruption of the signal transduction
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of stress. Although regulation of SERT by p38 had been impli-
cated based on in vitro studies (Zhu et al., 2005; Samuvel
et al., 2005), the demonstration that stress-induced p38a
MAPK causes translocation of SERT to the plasma membrane
in brain provides a clear molecular explanation for stress-
induced dysphoria. The data presented here show that in
serotonin neurons, p38a MAPK acts to directly influence SERT
trafficking and ultimately to increase the rate of serotonin reup-
take. In conclusion, understanding the molecular and cellular
mechanisms that control stress-induced behaviors delineates
the neurobiological mechanisms involved in depression and
addiction-like behaviors, while also providing insight to potential
therapeutic targets. Although prior studies have demonstrated
a role for p38a MAPK in cellular development and apoptotic
mechanisms, its role in the regulation of mood disorders and
addiction risk was not previously appreciated. Furthermore,
although antidepressant efficacies of drugs that inhibit the
plasma membrane serotonin transporter are clear, the profound
effects of stress on the serotonin system function defined by this
study provide key molecular insight into the underlying mecha-
nisms of stress-vulnerability and resilience.
EXPERIMENTAL PROCEDURES
For detailed Experimental Procedures, see Supplemental Information.
Animals
Experimental procedures were carried out in accordance with the USPHS
Guide for Care and Use of Laboratory Animals and were approved by the Insti-
tutional Animal Care and Use Committee at the University ofWashington. Male
C57BL/6 mice (20–30 g) were group-housed, four to a cage, in ventilated
mouse cages (Thoren Caging Systems, Hazelton, PA) within the Animal Core
Facility at the University of Washington, given access to food pellets and water
ad libitum, and maintained in specific pathogen-free housing.
Generation of Serotonin-Specific Conditional Knockout Mice
Breeding and genotyping procedures were as described in the Supplemental
Information.
Behavior
Conditioned Place Aversion
Mice were trained in an unbiased, balanced three-compartment conditioning
apparatus as described (Land et al., 2009; Bruchas et al., 2007).
Stress-Induced Social Avoidance and Stress-Induced Cocaine
Reinstatement
Stress-induced social avoidance and stress-induced cocaine reinstatement
was performed as described in the Supplemental Information.
Viral Preparation and Local Intracranial Injections
Viral preparation and local intracranial injections were performed as previously
reported (Zweifel et al., 2008; Land et al., 2009) and described more fully in the
Supplemental Information.
Immunohistochemistry
Immunohistochemistry was performed as previously described (Land et al.,
2009; Bruchas et al., 2007) and described more fully in the Supplemental
Information.
Synatosomes
Synatosomes were prepared from whole brain according to published proto-
cols (Hagan et al., 2010; Ramamoorthy et al., 2007) and describedmore fully in
the Supplemental Information.Rotating Disk Electrovoltammetry (RDEV)
RDEV was used to measure initial velocities of serotonin (5-HT) transport into
mouse synaptosomal preparations as previously described (Hagan et al.,
2010) and described more fully in the Supplemental Information.
Data Analysis/Statistics
Data are expressed as means ± SEM. Data were normally distributed, and
differences between groups were determined using independent t tests or
one-way ANOVA, or two-way ANOVAs followed by post hoc Bonferroni
comparisons if the main effect was significant at p < 0.05. Statistical analyses
were conducted using GraphPad Prism (version 4.0; GraphPad) or SPSS
(version 11.0; SPSS).
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.neuron.2011.06.011.
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